logo.gif (2253 bytes)



Home Page

Welcome

Committees

Sponsors

Advance Program

Posters Sessions:

General
Information

Pre and Post Congress Tours

Registered Accompanying Persons Program

Accommodation

Accommodation and Tour Form

Registration Form

 

ADVANCE PROGRAM
THURSDAY, OCTOBER 5, 2000

 

THURSDAY, OCTOBER 5, 2000

08:30 - 10:15 Hall A
PL11:  SURGERY FOR CORONARY ARTERY DISEASE
Chairpersons: G.P. Fontana, Los Angeles CA, USA
G. Uretzky, Haifa, Israel
 08:30  ANATOMICAL AND FUNCTIONAL LIMITS OF TOTAL ARTERIAL REVASCULARIZATION (Invited Lecture)
O. Jegaden, F. Farhat, L. Bontemps, P. Montagna, R. Itti, P. Mikaeloff, Lyon, France
 08:45  MYOCARDIAL REVASCULARIZATION: BETWEEN CABG AND GENE THERAPY (Invited Lecture)
R.G.H. Moosdorf, Marburg, Germany
 09:00  SURGICAL APPROACHES TO POSTINFARCTION LEFT VENTRICULAR REMODELING (Invited Lecture)
L.H. Edmunds, Jr., Philadelphia PA, USA
 09:15  SURGICAL OPTIONS FOR PATIENTS WITH END-STAGE HEART DISEASE (Invited Lecture)
F. Beyersdorf, G. Trummer, Freiburg, Germany
 09:30  COMPOSITE ARTERIAL GRAFTING WITH DOUBLE SKELETONIZED IMA
D. Pevni, I. Shapira, J. Gurevitch, M. Matsa, A. Kramer, R. Mohr, Tel Aviv, Israel
 09:45  THE IMPACT OF CORONARY ARTERY DISEASE ON SURVIVAL AFTER VALVE REPLACEMENT FOR NON-ISCHEMIC VALVE DISEASE (Invited Lecture)
J.S. Borer, New York NY, USA
 10:00  ACUTE AND LONG-TERM RESULTS AFTER CATHETER - BASED PERCUTANEOUS MYOCARDIAL LASER REVASCULARIZATION IN PATIENTS WITH END-STAGE CORONARY ARTERY DISEASE (Invited Lecture)
G. Schuler, S. Bratanow, B. Lauer, Leipzig, Germany
 10:15  HARVESTING THE SAPHENOUS VEIN WITH THE SOUZA "NOTOUCH" TECHNIQUE FOR CABG MAINTAINS HIGH FUNCTIONAL AND MORPHOLOGICAL ENDOTHELIAL INTEGRITY AND ACHIEVES A HIGH MIDTERM PATENCY RATE
D. Souza, J.C.S. Tsui, M.R. Dashwood, D. Filbey, V. Bomfim, Orebro, Sweden
 10:30  C o f f e e B r e a k

THURSDAY, OCTOBER 5, 2000

08:30 - 10:15 Hall B
S62:  INTERVENTIONAL CARDIOLOGY
Chairpersons: N. Reifart, Bad Soden / Ts., Germany
N. Khader, Haifa, Israel
 08:30  IS DIABETES A WORSE SETTING FOR PRIMARY PTCA AND STENTING?
C. Loubeyre, B. Villegas, S. Hernandez, T. Lefevre, M.C. Morice, P. Dumas, Y. Louvard, J.F. Piechaud, Quincy-sous-Senart, France
 08:45  EXTENT OF ACUTE RECOIL IN CORONARY STENTS: ASSESSMENT BY HIGH RESOLUTION SPECIMEN RADIOGRAPHY IN AN IN VITRO MODEL
R. Fuessl, T. Stolpmann, H.W. Hoepp, Ulm, Germany
 09:00  THE EFFECT OF OVERLAPPING CORONARY STENTS ON NEOINTIMAL HYPERPLASIA. INSIGHT FROM A PORCINE CORONARY STENT MODEL
I. De Scheerder, Q. Bei Ping, H. Yanming, H. Jianhua, L. Xiaoshun, M. Szilard, E. Verbeken, F. Van de Werf, Leuven, Belgium
 09:15  EFFICACY OF HEPARIN COATED STENT IN THE EARLY SETTING OF ACUTE MYOCARDIAL INFARCTION
E.K. Shin, M.S. Sohn, J.W. Son, T-H. Ahn, I.S. Choi, K.K. Koh, Inchon, South Korea
 09:30  RENAL ARTERY STENTING FOR ATHEROSCLEROTIC RENAL ARTERY STENOSIS
A. Ali, V. Guduguntla, M. Madoun, T. Schreiber, T. Davis, S. Kazziha, Detroit MI, USA
 09:45  TLR AFTER STENTING IN CORONARY BIFURCATION LESIONS : RESULTS OF A MULTICENTER PROSPECTIVE STUDY
P. Brunel, P. Commeau, R. Koning, M. Bedossa, M. Gilard, Nantes, France
 10:00  PTCA WITH AND WITHOUT IN-HOUSE CARDIAC SURGERY STANDBY: EXPERIENCES BY THE SAME GROUP OF OPERATORS AT TWO INSTITUTIONS (Invited Lecture)
N. Reifart, A. Wolf, H. Storger, R. Besser, S. Iversen, Bad Soden, Germany
 10:15  DIRECT INFARCT INTERVENTION IN THE DIABETIC: DOES IT REALLY WORK?
A. Bhaskaran, R. Siegel, B. Barker, A. Nuttall, W. Breisblatt, T. Khalil, D. Velarde, D. Frazier, J. Vermillion, S. Huemiller, Phoenix AZ, USA
 10:30  IMPACT OF STENTING ON THE CLINICAL OUTCOME AFTER ANGIOPLASTY OF THE LEFT ANTERIOR DESCENDING ARTERY
E. Schroeder, P. Chenu, O. Gurne, E. Rombaut, C. Laruelle, P. Colles, J.L. Paquay, P.E. Massart, J. Jamart, B. Marchandise, Yvoir, Belgium
  C o f f e e B r e a k

THURSDAY, OCTOBER 5, 2000

08:30 - 10:15 Hall C
S63:  PREVENTION, LIPIDS AND RISK FACTORS
Chairpersons: O. Abdel-Aziz, Cairo, Egypt
E. Bonnefoy, Lyon, France
 08:30  LIPIDS AND THE PATHOGENESIS OF CORONARY ARTERY DISEASE: THE LIPID PROFILE AMONG EGYPTIANS (LPE) PROJECT OF 10,000 PEOPLE (Invited Lecture)
O. Abdel-Aziz, Cairo, Egypt
 08:45  POSTPRANDIAL HYPERINSULINEMIA AND CORONARY ARTERY DISEASE IN WOMEN WITHOUT DIABETES
M. Baltali, M.E. Korkmaz, I.H. Muderrisoglu, B. Ozin, S. Topcu, F. Yalcin, F. Yigit, Adana, Turkey
 09:00  IS PREECLAMPSIA A RISK FACTOR FOR CAD IN WOMEN ?
R. Kaaja, M. Salminen, H. Laivuori, O. Ylikorkala, Helsinki, Finland
 09:15  BENEFICIAL EFFECTS OF ABOVE-NORMAL HDL CHOLESTEROL ON SECONDARY PREVENTION FOR POST-MYOCARDIAL INFARCTION PATIENTS
H. Yabushita, H. Takai, A. Nakano, T. Taniwa, M. Miyataka, A. Kimura, K. Katayama, Osaka, Japan
 09:30  A PROTOCOL TO TRANSLATE NUTRITIONAL RECOMMENDATIONS INTO CLINICAL PRACTICE IN SECONDARY PREVENTION OF CAD
R. Aquilani, F. Cobelli, A. Rossi, S. Verdirosi, S. Boni, V. Paganini, R. Riccardi, J. Assandri, A. Cajelli, M. Verri, F. Boschi, M. Catapano, M. Dossena, O. Pastoris, Montescano, Italy
 09:45  A MULTICENTER STUDY USING A COST-EFFECTIVENESS TREAT-TO-TARGET MODEL IN HYPERLIPIDEMIA MANAGEMENT WITH HMG-CO A REDUCTASE INHIBITOR MONOTHERAPY
D.B. Lucas, C.A. Sanoski, M.K. Ito, M.A. Aldridge, J.W.M. Cheng, D.E. Hilleman, Charleston WV, USA
 10:00  HOSTILITY, SOCIAL SUPPORT AND CORONARY HEART DISEASE IN THE NHLBI FAMILY HEART STUDY
S. Knox, K.D. Siegmund, G. Weidner, R.C. Ellison, A. Adelman, C. Paton, Bethesda MD, USA
 10:15  HOMOCYSTEINE - AN ESSENTIAL SUBSTRATE IN CORONARY ARTERY METABOLISM - AN IMMUNOHISTOCHEMICAL STUDY
M. Mehrabi, T. Wild, J. Wojta, F. Tamaddon, G. Gaul, N. Serbecic, K. Plesch, T. Thalhammer, K. Huber, H.D. Glogar, Vienna, Austria
10:30 AN IN VITRO STUDY ON THE ANTIOXIDANT CAPACITY OF STATINS
F. Franzoni, F. Regoli, F. Galetta, Pisa, Italy
  C o f f e e B r e a k

THURSDAY, OCTOBER 5, 2000

10:45 - 12:30 Hall A
PL12:  NEW TRENDS IN CARDIAC SURGERY
Chairpersons: J.A. Elefteriades, New Haven CT, USA
O. Jegaden, Lyon, France
 10:45  MINIMALLY INVASIVE CARDIAC SURGERY: LOOKING TO THE FUTURE THROUGH A KEYHOLE (Invited Lecture)
G.P. Fontana, Los Angeles CA, USA
 11:00  THREE YEARS EXPERIENCE WITH HYBRID REVASCULARIZATION
F.C. Riess, N. Bleese, P. Kremer, C. Kuhn, S. Moshar, T. Tuebler, J. Schofer, Hamburg, Germany
 11:15  MINI-STERNOTOMY AND OFF-PUMP METHOD IN SIMULTANEOUS CABG AND ABDOMINAL ANEURYSM REPAIR
Y. Takahara, Y. Sudo, Funabashi, Japan
 11:30  HEMODYNAMIC EFFECTS OF THE LIMA SUTURE IN BEATING HEART SURGERY
R. Lima, T.A. Salerno, Miami FL, USA
 11:45  SURGICAL MANAGEMENT OF ISCHEMIC MITRAL REGURGITATION (Invited Lecture)
J-F. Obadia, Lyon, France
 12:00  SURGICAL OPTIONS FOR END-STAGE CORONARY ARTERY DISEASE (Invited Lecture)
R. Hetzer, Berlin, Germany
 12:15  NEITHER EXTREME LV DILATION NOR LACK OF ISCHEMIA OR STRESS TESTING SHOULD CONTRAINDICATE CABG FOR ADVANCED ISCHEMIC CARDIOMYOPATHY (Invited Lecture)
J.A. Elefteriades, New Haven CT, USA
 12:30  LARGE ENCIRCLING CRYOABLATION WITHOUT MAPPING FOR VENTRICULAR TACHYCARDIA AFTER MYOCARDIAL INFARCTION
J.M. Frapier, R. Demaria, T. Aymard, J. Hubaut, R. Grolleau, B. Albat, P.A. Chaptal, Montpellier, France

THURSDAY, OCTOBER 5, 2000

10:45 - 12:30 Hall B
S64:  INTERVENTIONAL CARDIOLOGY
Chairpersons: D.A. Halon, Haifa, Israel
S. Saito, Kamakura, Japan
 10:45  IMPROVED LOCAL DRUG DELIVERY USING THE ELUT CORONARY STENT
I. De Scheerder, Y. Huang, Q.B. Ping, L. Wang, E. Schacht, Leuven, Belgium
 11:00  ANGIOGRAPHIC RESULTS OF THREE BARE CORONARY STENT TYPES COMPARED IN A DOUBLE-BLIND RANDOMIZED STUDY (PUNIPAST)
A. Machraoui, H. Baberg, S. von Dryander, S. Lange, P. Grewe, W. Bojara, A. Germing, Flensburg, Germany
 11:15  LONG TERM PROGNOSIS OF PATIENTS WITH PALMAZ-SCHATZ STENT. - OUTCOME AFTER 1500 DAYS
A. Fukuda, M. Kitayama, H. Akao, S. Ohkubo, S. Kanemitsu, N. Takekoshi,
Kahoku, Japan
 11:30  INCIDENCE OF STENT THROMBOSIS IN THE ERA OF PLATELET GLYCOPROTEIN IIB/IIIA INHIBITORS
A. Ali, M. Hashem, A. Rehan, T. LaLonde, N. Vikraman, T. Schreiber, J. Michael, D. Pieper, V. Lal, R. Nugaram, L. Moser, Detroit, MI, USA
 11:45  THE POSSIBLE RELATIONSHIP BETWEEN LEVELS OF SICAM-1 AND CLINICAL EVENTS AND ANGIOGRAPHIC RESTENOSIS IN-PATIENTS WITH STABLE ANGINA PECTORIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
B. Ilcol, J. Cordan, Y. Ilcol, K. Gemici, Bursa, Turkey
 12:00  EMERGENCY PTFE-COVERED STENT IMPLANTATION TO TREAT CORONARY RUPTURES
C. Briguori, T. Nishida, A. Anzuini, M.R. Albiero, C.F. Airoldi, D. Mario, E. Grube, A. Colombo, Milan, Italy

THURSDAY, OCTOBER 5, 2000

10:45 - 12:30 Hall C
S65:  HEART FAILURE, VENTRICULAR FUNCTION
Chairpersons: S. Castellani, Firenze, Italy
A. Merdler, Haifa, Israel
 10:45  THE EVALUATION OF PLEURAL EFFUSION IN CONGESTIVE HEART FAILURE AND THE RELATION TO DIURETICS
I. Gotsman, Z. Fridlender, M. Muszkat, A. Meirovitz, M. Gotsman, Jerusalem, Israel
 11:00  TISSUE DOPPLER IMAGING IN THE QUANTITATIVE ASSESSMENT OF SYSTOLIC AND DIASTOLIC RIGHT VENTRICULAR FUNCTION
A. Vitarelli, Y. Conde, R. Giubilei, G. Di Benedetto, A. Lamura, T. Leone, F. Fedele, Rome, Italy
 11:15  TISSUE DOPPLER MYOCARDIAL VELOCITY GRADIENT IN ISCHEMIC HEART DISEASE PRE AND POST PTCA
A. Vitarelli, Y. Conde, G. Di Benedetto, T. Leone, F. Fedele, Rome, Italy
 11:30  PREDICTION OF CARDIAC MORTALITY IN ISCHEMIC CARDIOMYOPATHY BY EVALUATION OF SIGNAL-AVERAGED ELECTROCARDIOGRAM AND SIMPLE ECHO-DOPPLER INDICES
G. Kazianis, M. Karpathiotakis, C. Tsoukala, G. Avgeropoulos, A. Economou,
Athens, Greece
 11:45  IMPAIRED CEREBROVASCULAR REACTION TO ADRENERGIC STIMULATION IN CONGESTIVE HEART FAILURE (Invited Lecture)
S. Castellani, N. Boni, I. Carobbi, Gf. Gensini, Firenze, Italy
 12:00  ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IMPROVES THE MYOCARDIAL REMODELING AND NEUROHUMORAL STATUS IN PATIENTS WITH CONGESTIVE HEART FAILURE DOSE-DEPENDENTLY
A.E. Berezin, Zaporoshye, Ukraine
 

This site was developed by .